(⁎)Renal Division, Department of Medicine, Peking University First Hospital, Peking University, Beijing, China; (†)Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; (‡)Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China.
(⁎)Renal Division, Department of Medicine, Peking University First Hospital, Peking University, Beijing, China; (†)Institute of Nephrology, Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China; (‡)Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China.
Semin Nephrol. 2020 Sep;40(5):506-515. doi: 10.1016/j.semnephrol.2020.08.007.
Acute kidney injury (AKI) has become a worldwide public health problem, resulting in a high risk of mortality and progression to chronic kidney disease. Peritoneal dialysis (PD) can be an effective renal support for AKI, especially in regions where medical resources are limited, but actually underused. In this article, the current barriers and challenges of use of PD in AKI are discussed, including health strategy and medical resources, PD team organization, and technique-specific factors. Currently, we are just on the starting line of the campaign of acute PD. It is still a long way to the development of PD as a mature treatment in AKI.
急性肾损伤（AKI）已成为全球性公共卫生问题，导致死亡率和进展为慢性肾脏病的风险增加。腹膜透析（PD）可以是 AKI 的有效肾脏支持，特别是在医疗资源有限的地区，但实际上未得到充分利用。本文讨论了 PD 在 AKI 中的应用所面临的当前障碍和挑战，包括卫生策略和医疗资源、PD 团队组织以及技术相关因素。目前，我们刚刚处于急性 PD 运动的起跑线上。PD 要发展成为 AKI 的成熟治疗方法，还有很长的路要走。
